M.E.D.U.S.A. Scalper Indicator

This is WHY (ALBT) Should Trade Much Higher on Valuation of Recent Profitable Acquisition

Trader Alert! Premium Alert (ALBT) Is Trading Pre-Market Right Now Signaling a Breakout -- Do NOT Miss This Next Move Hi 10XProTrader Member, Do NOT miss this breakout. (ALBT) is starting to get a lot of attention by Wall Street. This pre-market trading is a very bullish indicator for a big move! (ALBT) acquired a very profitable company that instantly injected positive cash flow. They also acquired a patented FDA registered medical device for men. When (ALBT) releases its next Quarterly report, the entire valuation for the stock will have suddenly changed for the good. The question is would you like to know this information BEFORE the giant crowd of traders jump on it, or after? Avalon's Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Device FREEHOLD, N.J., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. ("Avalon" or the "Company") (NASDAQ: ALBT), a developer of innovative precision diagnostics and provider of clinical laboratory services, today announced Laboratory Services MSO, LLC ("LSM"), has acquired Merlin Medical Supply ("MMS"), a profitable, well-established Home Medical Equipment ("HME") and Durable Medical Equipment ("DME") company providing acute and non-acute medical supplies in Ventura County, California. Additionally, LSM has acquired Leading Edge Innovations, LLC from the same owner. Leading Edge Innovations owns the GeeWhiz External Condom Catheter, a patented, FDA-registered, in-market, male incontinence device. Avalon owns a 40% interest in LSM. MMS "Now part of ALBT" has contracts with major healthcare payers, including Medicaid, Medicare, Medi-Cal, Optum-Rx, CCS, Tri-Care, Blue Cross/Blue Shield, Humana, Aetna, United Health and Gold Coast. Avalon Uncovered: 7 Investor Highlights That Everyone Needs to Know Avalon Has an Extremely Low Float Producing Very High Volatile Swings In Price Movement Avalon Announces Notice of Publication for Key U.S. Patent Filed Jointly with the Massachusetts Institute of Technology (MIT) Avalon Subsidiary Launches New Laboratory Test For Tuberculosis Avalon Laboratory Services MSO Announces Expansion into Arizona Avalon Laboratory Services MSO Acquires Texas Lab with Significant Potential Growth Avalon Reports Strong financial Results Laboratory Services MSO Revenue of $14.7Mln and Net Income of $6.3Mln in 2022 Avalon Has Recently Bounced Off Its Support Level of $1.00/share Twice In The Last 30 Days for 30% Short=Term Gains Why Should You Pay Close Attention to (NASDAQ: ALBT)? Because... 10XProTrader consistently produces real-time gains like you see right below. >>>> Interested In Potential Gains Like These Below <<<< • (NAOV): Open at $2.10 8/30 – High $4.23 8/3/20 (101% Gains) • (PRFX): Pre-Mkt at $5.37 7/3 – High $26.41 7/11 (391% Gains) • (LIXT): Pre-Mkt at $5.26 7/17 – High $9.50 7/11 (80% Gains) • (PWM): Pre-Mkt at $10.00 7/7 – High $31.88 7/11 (218% Gains) • (DERM): Pre-Mkt at $1.50 7/3 – High $3.19 7/10 (112% Gains) • (CRBU): Pre-Mkt at $4.13 7/6 – High $7.78 7/10 (88% Gains) • (GRRR): Pre-Mkt at $3.25 7/7 – High $6.98 7/10 (114% Gains) • (MOB): Pre-Mkt at $1.57 7/10 – High $3.33 (112% Gains) Every single stock symbol you see above is a real-time alert that I released to my 10X community. These are NOT fake alerts! CATALYST: Key Driver For Exceptional Shareholder Growth - ALBT Executes NEW "Merger & Acquisitions" "Roll-Up Strategy" Creating A Biotech Powerhouse, and Pipeline of Potential Acquisitions With Avalon expanding its "R&D Pipeline" and "intellectual property Portfolio" produces a strong catalyst for incredible upside potential. Conclusion: You are the first to know about this recent bombshell news that was just recently released several days ago that change the entire dynamics of shareholder value. If you haven't taken a look at ALBT yet, this is your chance! Today is a critical day for you to pay close attention! 10X Your Wealth,

Kevin Vander Publisher, 10XProTrader.com Investment Research

You are receiving this e-mail as part of your subscription to 10XProTrader. Please do not reply to this e-mail as this address is not monitored. Our Customer Service team is available Monday - Friday between 9:00 AM and 5:00 PM ET. © 2023 10XProTrader.com. All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular inves∙tment situation. N∙o communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers, prior or during our reporting on the company. © 2023 10XProTrader.com, All Rights Reserved. 10XProTrader is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or inve∙stment for any specific individual. This communication is a paid a∙dvertisement. 10XProTrader.com and/or its subsidiaries and/or affiliates ("Company," "we," or "us") have been compensated $30,000 USD to disseminate this communication. We have never received stock in ALBT, nor have we traded it. Please note that we do not trade any securities that we profile. We do not hold positions in stocks we profile. We do not except stock as a form of payment for our profiles. Please review the full disc∙laimer at https://10xprotrader.com/disc-laimer for important information about this advertisement.

© 2023 10XProTrader. All rights reserved., 340 Royal Poinciana Way Suite 317, 33480, Palm Beach, United States You may unsubscribe or change your contact details at any time.